Home LiteratureArticle Details
PMID: 8642334 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro.

The Journal of experimental medicine ·Vol. 183 ·No. 5 ·1996-05-01 ·Pages 2247-57

Cai Z, Sprent J

Abstract

The influence of costimulation on the primary response of CD8+ T cells to class I alloantigens was studied with the aid of a T cell receptor transgenic model and defined peptides as antigen. With small doses of antigen, the proliferative response of CD8+ cells was high early in culture but was of brief duration and declined to low levels by day 4; this abbreviated response was associated with limited production of interleukin 2 (IL-2) and was strongly dependent upon costimulation via CD8-major histocompatibility complex class I and CD28-B7 interactions. The response to large doses of antigen was quite different in two respects. First, large doses of antigen inhibited the early (day 3) proliferative response but caused a marked elevation of the response late in culture (day 5); these altered kinetics were associated with increased production of IL-2. Second, the initial proliferative response to large doses of antigen did not require costimulation: indeed, blocking costimulation with CTLA4lg or anti-CD8 monoclonal antibody enhanced the early proliferative response. However, blocking costimulation impaired IL-2 production and prevented the late proliferative response. These findings indicate that the requirement for costimulation of T cells can be partly overcome by increasing the dose of antigen to a high level. However, costimulation plays a key role in prolonging the response, presumably by triggering strong and sustained production of IL-2.

MeSH Terms
Abatacept Amino Acid Sequence Animals Antigens, CD Antigens, Differentiation/immunology Binding Sites CD28 Antigens/immunology CTLA-4 Antigen Cells, Cultured DNA/biosynthesis Flow Cytometry Histocompatibility Antigens Class I/immunology Humans Immunoconjugates Interleukin-2/biosynthesis Isoantigens/immunology Kinetics Lymphocyte Activation Mice Mice, Inbred Strains Mice, Transgenic Molecular Sequence Data Peptide Fragments/immunology Receptors, Antigen, T-Cell/biosynthesis,immunology T-Lymphocytes, Cytotoxic/immunology Thymidine/metabolism Time Factors
Chemicals
Antigens, CD Antigens, Differentiation CD28 Antigens CTLA-4 Antigen CTLA4 protein, human Ctla4 protein, mouse Histocompatibility Antigens Class I Immunoconjugates Interleukin-2 Isoantigens Peptide Fragments Receptors, Antigen, T-Cell Abatacept DNA Thymidine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Cai Z
Department of Immunology, Scripps Research Institute, La Jolla, California 92037, USA.
Sprent J
References (33)
33 references, click to expand
  1. T cell reactivity to MHC molecules: immunity versus tolerance.
    Science. 1990 Jun 15;248(4961):1357-63 PMID: 1694041
  2. Evidence for CD8-independent T cell maturation in transgenic mice.
    J Immunol. 1990 May 1;144(9):3318-25 PMID: 2109775
  3. Positive selection of transgenic receptor-bearing thymocytes by Kb antigen is altered by Kb mutations that involve peptide binding.
    Proc Natl Acad Sci U S A. 1990 Aug;87(16):6186-90 PMID: 2117275
  4. Antigen-presenting cells for Lyt-2+ cells. II. Primary mixed-lymphocyte reactions stimulated by Ia+ dendritic cells and Ia- peritoneal exudate cells.
    Int Immunol. 1989;1(5):517-25 PMID: 2535141
  5. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation.
    Annu Rev Immunol. 1992;10:645-74 PMID: 1534242
  6. Major histocompatibility complex (MHC)-encoded HAM2 is necessary for antigenic peptide loading onto class I MHC molecules.
    J Biol Chem. 1992 Jun 15;267(17):11669-72 PMID: 1339432
  7. A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein.
    Cell. 1992 Jun 12;69(6):989-98 PMID: 1606619
  8. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    J Exp Med. 1992 Dec 1;176(6):1595-604 PMID: 1334116
  9. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.
    Cell. 1992 Dec 24;71(7):1065-8 PMID: 1335362
  10. The role of the CD28 receptor during T cell responses to antigen.
    Annu Rev Immunol. 1993;11:191-212 PMID: 8386518
  11. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
    J Exp Med. 1993 Jun 1;177(6):1791-6 PMID: 7684435
  12. Role of CD4 and CD8 in T cell activation and differentiation.
    Adv Immunol. 1993;53:59-122 PMID: 8512039
  13. Differential T cell costimulatory requirements in CD28-deficient mice.
    Science. 1993 Jul 30;261(5121):609-12 PMID: 7688139
  14. Avidity for antigen can influence the helper dependence of CD8+ T lymphocytes.
    J Immunol. 1993 Dec 1;151(11):5993-6001 PMID: 8245444
  15. A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone.
    Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11272-6 PMID: 8248240
  16. Signals and signs for lymphocyte responses.
    Cell. 1994 Jan 28;76(2):275-85 PMID: 7904901
  17. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.
    Science. 1994 Feb 25;263(5150):1139-43 PMID: 7509084
  18. Resting and activated T cells display different requirements for CD8 molecules.
    J Exp Med. 1994 Jun 1;179(6):2005-15 PMID: 8195722
  19. The degree of CD8 dependence of cytolytic T cell precursors is determined by the nature of the T cell receptor (TCR) and influences negative selection in TCR-transgenic mice.
    Eur J Immunol. 1994 Jul;24(7):1572-7 PMID: 8026519
  20. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity.
    Science. 1994 Aug 12;265(5174):946-9 PMID: 8052850
  21. The B7 and CD28 receptor families.
    Immunol Today. 1994 Jul;15(7):321-31 PMID: 7522010
  22. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins.
    Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11487-91 PMID: 7972089
  23. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.
    Nature. 1994 Dec 8;372(6506):570-3 PMID: 7990932
  24. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes.
    Immunity. 1994 Apr;1(1):15-22 PMID: 7889394
  25. Absence of B7-dependent responses in CD28-deficient mice.
    Immunity. 1994 Sep;1(6):501-8 PMID: 7534617
  26. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.
    Science. 1995 Nov 10;270(5238):985-8 PMID: 7481803
  27. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.
    Immunity. 1995 Nov;3(5):541-7 PMID: 7584144
  28. Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes.
    Proc Natl Acad Sci U S A. 1984 Dec;81(24):7922-6 PMID: 6334855
  29. Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo.
    Immunol Rev. 1986 Jun;91:195-218 PMID: 2942460
  30. Antigen-induced suppression of the proliferative response of T cell clones.
    J Immunol. 1988 Mar 1;140(5):1359-65 PMID: 2450125
  31. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice.
    Nature. 1988 Sep 15;335(6187):271-4 PMID: 3261843
  32. Antigen recognition by H-2-restricted cytolytic T lymphocytes: inhibition of cytolysis by anti-CD8 monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen.
    Eur J Immunol. 1988 Nov;18(11):1863-6 PMID: 3144458
  33. Empty MHC class I molecules come out in the cold.
    Nature. 1990 Aug 2;346(6283):476-80 PMID: 2198471
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1996-05-01
Pages
2247-57
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2192558
Subset
IM
Grants
NIAID NIH HHS · AI-32068 · United States
NCI NIH HHS · CA-25803 · United States
NCI NIH HHS · CA-38355 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]